General
Preferred name
ALFACALCIDOL
Synonyms
Alfacalcidol-D6 ()
1-hydroxycholecalciferol ()
1.alpha.-Hydroxyvitamin D3 ()
1.alpha.(oh)d3 ()
Oxydevit ()
1-hydroxyvitamin d3 ()
1.alpha-hydroxycholecalciferol ()
1.alpha.-hydroxycholecalciferol ()
Einsalpha ()
One-Alpha ()
.alpha.-calcidol ()
Tevabone ()
1-alpha-vitamin d ()
Un alfa ()
Alpharol ()
Bondiol ()
Alfarol ()
Alpha d3 ()
Un alpha ()
Alphacalcidol ()
Alfa D ()
Etalpha ()
Alsiodol ()
1-hydroxy Vitamin D3 ()
P&D ID
PD009493
CAS
125324-15-4
41294-56-8
Tags
available
drug
prodrug
First approval
1978
Drug Status
approved
investigational
nutraceutical
Max Phase
4.0
Drug indication
Osteoporosis
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
INDICATION
Indicated for the management of hypocalcemia, secondary hyperparathyroidism, and osteodystrophy in patients with chronic renal failure.[label]
PRICE
86
DESCRIPTION
Alfacalcidol (Etalpha) (1-hydroxycholecalciferol; Alpha D3; 1.alpha.-Hydroxyvitamin D3) is a non-selective VDR activator medication.
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
13
AdooQ Bioactive Compound Library
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
LSP-MoA library (Laboratory of Systems Pharmacology)
MedChem Express Bioactive Compound Library
Other bioactive compounds
ReFrame library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
69
Molecular Weight
400.33
Hydrogen Bond Acceptors
2
Hydrogen Bond Donors
2
Rotatable Bonds
6
Ring Count
3
Aromatic Ring Count
0
cLogP
6.59
TPSA
40.46
Fraction CSP3
0.78
Chiral centers
6.0
Largest ring
6.0
QED
0.53
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
VD/VDR
CYP27B1, VDR
Environmental Pollutants
Pathway
Vitamin D Related
Vitamin D Related/Nuclear Receptor
Indication
vitamin D deficiency
MOA
vitamin D receptor agonist
Source data

